Parkinson's disease symptoms are reduced
The role of interleukin-6 in insulin resistance, body fat distribution and energy balance
The antibodies used for the immunoblot assays were: GCLC (Santa Cruz Biotech, #sc-390811), NQO1 (Sigma Prestige Antibodies, HPA007308), ACTIN (Sigma, A1978), NRF2 (Cell Signaling Technology, #12721), NRF1 (Cell Signaling Technology, #8052), YAP/TAZ (Cell Signaling, #8418) 4-HNE (Abcam, #ab46545) and Lamin A/C (Cell Signaling, #4777)
Its role in human physiology is multifaceted: Stimulates insulin secretion from pancreatic beta cells Suppresses glucagon release from alpha cells Slows gastric emptying, improving satiety Acts on the brain, reducing appetite and promoting satiety Unlike insulin, which has been a focus of metabolic treatment for over a century, GLP-1s therapeutic potential was not fully appreciated until the late 20th century